This company listing is no longer active
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
@Health SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.60 |
| 52 Week High | €0 |
| 52 Week Low | €0 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -57.14% |
| 5 Year Change | -91.78% |
| Change since IPO | -90.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| MLAHC | FR Medical Equipment | FR Market | |
|---|---|---|---|
| 7D | 0% | 0.001% | -0.03% |
| 1Y | n/a | 14.7% | 1.8% |
Return vs Industry: Insufficient data to determine how MLAHC performed against the French Medical Equipment industry.
Return vs Market: Insufficient data to determine how MLAHC performed against the French Market.
Price Volatility
| MLAHC volatility | |
|---|---|
| MLAHC Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 5.7% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in FR Market | 9.7% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: MLAHC has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MLAHC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | Jean-Pascal Peyret | www.healthcardionexion.com |
@Health SA develops medical devices worldwide. It offers CardioNexion, a medical device to real time system for accessing risk of cardiovascular diseases. The company was incorporated in 2015 and is based in Aix-en-Provence, France.
@Health SA Fundamentals Summary
| MLAHC fundamental statistics | |
|---|---|
| Market cap | €3.04m |
| Earnings (TTM) | -€130.21k |
| Revenue (TTM) | €478.36k |
0.0x
P/S Ratio0.0x
P/E RatioIs MLAHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MLAHC income statement (TTM) | |
|---|---|
| Revenue | €478.36k |
| Cost of Revenue | €0 |
| Gross Profit | €478.36k |
| Other Expenses | €608.57k |
| Earnings | -€130.21k |
Last Reported Earnings
Dec 31, 2016
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MLAHC perform over the long term?
See historical performance and comparison